RPI-78M Uses, Dosage, Side Effects and more
RPI-78M is being developed for the treatment of multiple sclerosis (MS). Other neurological disorders that may be served by RPI-78M include myasthenia gravis (MG), muscular dystrophy (MD) and amyotrophic lateral sclerosis (ALS).
| Attribute | Details |
|---|---|
| Trade Name | RPI-78M |
| Generic | RPI-78M |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in multiple sclerosis, neurologic disorders, and pain (acute or chronic).
How RPI-78M works
RPI-78M contains anticholinergic peptides that recognize the same receptors as nicotine (acetylcholine receptors) but have the opposite effect.
